Author

Eva Sticova 1

1 Institute for Clinical and Experimental Medicine,Prague,Czech Republic

DONOR TM6SF2 RS58542926 GENOTYPE IS AN INDEPENDENT RISK FACTOR FOR DEVELOPMENT OF STEATOSIS AFTER LIVER TRANSPLANTATION

Irena Hejlova, Magdalena Neroldova, Jaroslav Hubacek, Dana Dlouha, Libor Kolesar, M. Jirsa, Eva Honsova, Eva Sticova, Vera Lanska, Julius Spicak, Pavel Trunecka

Long-term results of endoscopic treatment vs. esophagectomy with lymphadenectomy in patients with high-risk early esophageal cancer including detailed analysis of lymph node micrometastases

Kristina Ottavova, Marek Kollar, Jana Krajciova, Eva Sticova, Jana Maluskova, Alexandr Pazdro, Tomas Harustiak, Daniela Kodetova, Zuzana Vackova, Julius Spicak, Jan Martinek

PREVALENCE OF INSULIN RESISTANCE IN PATIENTS BEFORE AND AFTER LIVER TRANSPLANTATION, AND ITS PROGRESSION DURING THE FOLLOW-UP. A PROSPECTIVE STUDY

Irena Mikova, Petr Sedivy, Miloslav Drobny, Monika Dezortova, Milan Hajek, Monika Cahova, Helena Dankova, Eva Sticova, Vera Lanska, Denisa Erhartova, Julius Spicak, Pavel Trunecka

Recurrence of primary biliary cholangitis after liver transplantation: a single center experience

Pavel Drastich, Lukas Bajer, Klara Chmelova, Jan Březina, Peter Macinga, Eva Sticova, Pavel Trunecka, Pavel Taimr, Julius Spicak

RISK FACTORS FOR PRIMARY SCLEROSING CHOLANGITIS RECURRENCE AFTER LIVER TRANSPLANTATION

Lukas Bajer, Eva Sticova, Peter Macinga, Radim Janoušek, Pavel Trunecka, Julius Spicak, Pavel Drastich

Item 1 - 5 / 5
1